Document is current
Any future updates will be listed below
-
Authors
Amadid, Hanan
Clemmensen, Kim Katrine Bjerring
Vistisen, Dorte
Persson, Frederik
Jørgensen, Marit Eika
-
Funding
Funding for this research was provided by:
Sanofi-Aventis Deutschland
- License Information
-
More Information
Article History
Received: 15 July 2022
Accepted: 12 October 2022
First Online: 23 November 2022
Declarations
:
: According to Danish law, ethical approval and patient consent is not required for register studies. Access and use of the described register data are approved by the Danish Data Protection Agency and Danish Health Data Agency (j-No: SDC-2017-026 and FSEID-00003715).
: Not applicable.
: MEJ, HA. DV and KKBC own shares in Novo Nordisk A/S. MEJ has received research grants from Astra Zeneca, Sanofi Aventis, AMGEN, and Boehringer Ingelheim. FP reports having received research grants from AstraZeneca, Novo Nordisk and Novartis and lecture fees from Novartis, Eli Lilly, MSD, AstraZeneca, Sanofi, Novo Nordisk and Boehringer Ingelheim and having served as a consultant for Astra Zeneca, Bayer, Amgen, Novo Nordisk and MSD. KKBC is currently employed by Novo Nordisk A/S. No other potential conflicts of interest relevant to this article were reported for the remaining authors.
